Navigation Links
Reimbursement Cuts Will Challenge Japanese Interventional Cardiology Device Market
Date:4/3/2013

TORONTO, April 3, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, prices of interventional cardiology devices in Japan will see significant declines through 2021. The Japanese Ministry of Health, Labor and Welfare (MHLW) is implementing reimbursement cuts every two years in an effort to align Japanese medtech prices with the global market. As a result, most devices, including new products on the market, will see total revenue loss despite increases in use.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36799LOGO )

The Japanese interventional cardiology device market has seen many recent product launches, particularly stents, and a number of next-generation devices are set to launch over the next ten years. Although bioresorbable vascular scaffolds (BVS) and next-generation drug-eluting stents (DES) are premium devices and will see strong adoption upon entry to the market, the reimbursement cuts will limit prices and impede profits for these products as well.

"The effects of MHLW reimbursement won't be entirely negative," said MRG Analyst Louise Murphy . "Reimbursement coverage by device will encourage physicians to adopt premium devices over standard devices. Despite the biennial cuts, premium devices will maintain higher prices and better reimbursement rates than standard devices, such as bare-metal stents (BMS), and will allow manufacturers to somewhat offset aggregate price declines."

In addition, MHLW coverage of fractional flow reserve (FFR) guidewires was recently expanded to include use in diagnostic procedures, and this offers a huge growth opportunity. Because physicians are reimbursed by device rather than procedure, this expansion has removed barriers to adoption of FFR as a decision-making tool. In fact, the intravascular imaging catheter and pressure guidewire market will be the only segment to expand overall through 2021.

Major competitors in the FFR guidewire space, including Volcano and St. Jude Medical, continue to focus on innovation in an effort to gain market share. This strategy is more difficult for smaller companies, given the high cost of entering the market and the shrinking profit margins in the wake of MHLW reimbursement reform. Therefore, the major players in this market are likely to maintain their lead.

Millennium Research Group's Japanese Markets for Interventional Cardiology Devices 2013 report includes unit, procedure, average selling price and revenue information, along with market drivers and limiters and a competitive landscape for coronary stents, percutaneous transluminal coronary angioplasty (PTCA) balloon catheters, accessory devices, and intravascular imaging catheters and pressure guidewires in Japan.

About Millennium Research Group
Millennium Research Group (www.MRG.net), a Decision Resources Group company (www.DecisionResourcesGroup.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

Christopher Comfort

Decision Resources Group

781-993-2597

ccomfort@dresources.com

Alex Jablokow

Millennium Research Group

617-599-8613

ajablokow@mrg.net


'/>"/>
SOURCE Millennium Research Group
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Pricing and Reimbursement in Russia - Big Pharma Take Advantage of Reimbursement for Costly Drugs Through the DLOs Seven Nosologies Program
2. Education, Reimbursement Options are Key Components of Effective Pharmaceutical Brand Websites
3. New Study Answers CMS/USPSTF Concerns for CT Colonography Screening Reimbursement: It is a Viable Option for the Medicare-Aged Population
4. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
5. Endoscopy Devices Market to 2018 - Demand for Cost-Effective, Minimally Invasive Procedures and Reimbursement for New Indications to Increase Uptake
6. Questcor to Conduct Conference Call to Discuss Reimbursement Process
7. Global Healthcare, Regulatory and Reimbursement Landscape Forecasts and Trends in UAE, Canada and Taiwan
8. Boston Healthcare Expands Health Economics, Pricing, and Reimbursement Consulting Practice in Asia
9. Pharmaceutical Pricing and Reimbursement in China - Series of Mandated Price Cuts Not Effective in Stemming Healthcare Expenditures
10. Reimbursement Rates to Have Strong Effect on Adoption of Minimally Invasive Vertebral Compression Fracture Treatments
11. Home Hemodialysis Patients Urge Medicare to Fix HHD Training Reimbursement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):